MARKET

CVAC

CVAC

Curevac B.V.
NASDAQ
3.470
-0.120
-3.34%
After Hours: 3.470 0 0.00% 16:05 05/09 EDT
OPEN
3.540
PREV CLOSE
3.590
HIGH
3.585
LOW
3.400
VOLUME
619.07K
TURNOVER
--
52 WEEK HIGH
5.28
52 WEEK LOW
2.370
MARKET CAP
781.29M
P/E (TTM)
4.632
1D
5D
1M
3M
1Y
5Y
1D
Biotech Outperformance - Can't Take What's Already Earned
Seeking Alpha · 1d ago
Weekly Report: what happened at CVAC last week (0428-0502)?
Weekly Report · 5d ago
Curevac Is Maintained at Buy by UBS
Dow Jones · 04/30 14:32
Weekly Report: what happened at CVAC last week (0421-0425)?
Weekly Report · 04/28 10:38
Weekly Report: what happened at CVAC last week (0414-0418)?
Weekly Report · 04/21 10:38
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
NASDAQ · 04/17 14:51
CureVac’s Uncertain Prospects Amid Operational Restructuring and Pipeline Challenges
TipRanks · 04/14 10:36
Weekly Report: what happened at CVAC last week (0407-0411)?
Weekly Report · 04/14 10:31
More
About CVAC
More
CureVac NV, formerly CureVac AG, is a Germany-based clinical-stage biopharmaceutical company. The Company develops transformative medicines based on messenger ribonucleic acid, or mRNA. The Company's mRNAs are designed to prevent infections and to treat diseases by mimicking human biology to synthesize the desired proteins. Its technology platform optimizes mRNA constructs that encode functional proteins which either induce a desired immune response or replace defective or missing proteins using the cell’s intrinsic translation machinery. The Company's product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and molecular therapy. In prophylactic vaccines, the Company is advancing its second-generation mRNA backbone against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and a range of infectious diseases, including seasonal influenza, in collaboration with GSK(Glaxo Smith Kline).
Recently
Symbol
Price
%Change

Webull offers CureVac BV stock information, including NASDAQ: CVAC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CVAC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CVAC stock methods without spending real money on the virtual paper trading platform.